News | October 18, 2021
WHO to take call on Covaxin's EUL on October 26th
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
If approved it will bring a second source of MMR vaccine to the US market
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
India produces 60% of the world’s vaccine
Subscribe To Our Newsletter & Stay Updated
